Patient with BRAF mutation under kinase inhibitor therapy and controlled systemic disease developing 3 asymptomatic 1-2cm large brain metastases

Date 10 September 2017
Event ESMO 2017 Congress
Session Treating patients with melanoma brain metastases
Topics Anti-Cancer Agents & Biologic Therapy
Melanoma and other Skin Tumours
Presenter Paolo Ascierto
Authors P.A. Ascierto
  • Melanoma, Cancer Immunotherapy And Innovative Therapy Unit, Istituto Nazionale Tumori – I.R.C.C.S - Fondazione Pascale, 80131 - Naples/IT